Family office capital moved across yacht construction, mortgage banking, healthcare technology and biotech this week, with one family office deepening its bet on a clinical-stage cancer drug developer and another entering the superyacht business.
July 31 — Duquesne Family Office, a New York-based private investment firm founded in 2010 by billionaire investor Stanley Druckenmiller and an existing investor, participated in Ratio Therapeutics’ $70 million Series C financing, alongside Bristol Myers Squibb and new investors including Eli Lilly and Company. (BioSpace)
July 31 — Gottesman Real Estate Partners, an affiliate of Edison Investment Advisors, a family office established by the late Harold Gottesman, saw its first multifamily investment reach a milestone: Jefferson Place, a luxury apartment community in Jefferson Township, New Jersey, achieved full lease-up of its first phase. (Yahoo! Finance)
July 29 — Mitchell Companies, a family office and investment platform founded by Mark Mitchell, led a $12 million private placement in Marpai, a healthcare technology company. (PR Newswire)
July 27 — TGG Group, a Hong Kong single-family office led by Barry Lau, invested in Central Yacht, a Hong Kong-based yacht builder. (Superyacht Times)